Alhambra Investment Partners LLC Astrazeneca PLC Transaction History
Alhambra Investment Partners LLC
- $206 Million
- Q3 2025
A detailed history of Alhambra Investment Partners LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Alhambra Investment Partners LLC holds 5,575 shares of AZN stock, worth $498,405. This represents 0.21% of its overall portfolio holdings.
Number of Shares
5,575
Previous 4,580
21.72%
Holding current value
$498,405
Previous $320,000
33.44%
% of portfolio
0.21%
Previous 0.16%
Shares
2 transactions
Others Institutions Holding AZN
# of Institutions
1,499Shares Held
500MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...